Too Old to Operate22h
ENBALV: Edoxaban or Warfarin as Anticoagulant After Bioprosthetic Valve Replacement?
In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...
Too Old to Operate22h
SUMMIT: Tirzepatide Reduces Cardiovascular Events in HFpEF Plus Obesity
In the phase 3 SUMMIT trial, tirzepatide, was found to reduce the risk for worsening heart failure in patients with preserved ...